This paper presents an analysis of the Arruda accessory pathway localization method (for patients suffering from Wolff-Parkinson-White syndrome) with suggestions to increase the overall performance. The Arruda method was tested on a total of 121 patients, and a 90% localization performance was reached. This was considered almost as performing result as the highest published (90%) by L. Boersma in 2002. After a deeper analysis of each decision point of Arruda localization method we considered that the lead AVF is not as relevant as other used leads (I, II, III, V1). The overall performance (90%) was slightly lower then the correct decision rate (91.67%) at the weakest decision element (AVF+) of the method. The vectorial space constructed from the most used leads (II, V1, AVF) is not orthogonal which can be a reason for weaker rate in case of AVF.